Patent 11918685 was granted and assigned to Azurity Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.
Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).